Antibodies against the human cellular 3,3',5-triiodo-L-thyronine-binding protein (p 58).
High-titer antibodies against a cellular thyroid hormone-binding protein (Mr 58,000, p58) were developed by a special immunization method. To enhance immune responses, this method uses a boosting protocol in which repeated injections of small amounts of antigen are administered at 2-day intervals. Antibodies were detected 1 week after the last injection of antigen by ELISA, Western dot blotting and immunoprecipitation. The anti-p58 antibodies recognized p58 which is bound to the thyroid hormone. With the availability of anti-p58 antibodies, it has become possible to study cellular localization and function.